News

New Report on Drugs for Drug-resistant TB

The Médecins Sans Frontières and The Union will release on World TB Day a new report entitled “DR-TB drugs under the microscope” outlining drugs currently available to treat drug-resistant tuberculosis (DR-TB) including product information, sources of the drug, quality status, and price. The purpose of the report is to act as an aid to treatment providers, treatment programs, and national procurement centers in making decisions about which drugs to purchase and implement.

The report groups available TB drugs into five categories: 1) first-line oral agents 2) injectable agents 3) fluoroquinolones 4) Oral bacteriostatic second-line agents 5) Agents with unclear efficacy. The focus of the report is to detail the information on the drugs in groups 2 through 5.

In addition, the report presents an overview of the market and looks at challenges that are present when addressing DR-TB such as limited number of quality sources, affordability, and neglect of children and people living with HIV/AIDS. The report aims to provide quality information and to be transparent regarding pricing of these drugs.

The online Global TB Drug Pipeline available on the WGND website is cited in the report (see page 11 and 45).

Click here to read full report.

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...